Vitamin D3-implications for brain development.
There is growing evidence that 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) is active in the brain but until recently there was a lack of evidence about its role during brain development. Guided by certain features of the epidemiology of schizophrenia, our group has explored the role of 1,25(OH)(2)D(3) in brain development using whole animal models and in vitro culture studies. The expression of the vitamin D receptor (VDR) in the embryonic rat brain rises steadily between embryonic day 15-23, and 1,25(OH)(2)D(3) induces the expression of nerve growth factor and stimulates neurite outgrowth in embryonic hippocampal explant cultures. In the neonatal rat, low prenatal vitamin D(3) in utero leads to increased brain size, altered brain shape, enlarged ventricles, reduced expression of nerve growth factors, reduced expression of the low affinity p75 receptor and increased cellular proliferation. In summary, there is growing evidence that low prenatal levels of 1,25(OH)(2)D(3) can influence critical components of orderly brain development. It remains to be seen if these processes are of clinical relevance in humans, but in light of the high rates of hypovitaminosis D in pregnant women and neonates, this area warrants further scrutiny.
McGrath
John J
JJ
Queensland Centre for Schizophrenia Research, The Park Centre for Mental Health, Wacol, Australia. john_mcgrath@qcsr.uq.edu.au
Féron
François P
FP
Burne
Thomas H J
TH
Mackay-Sim
Alan
A
Eyles
Darryl W
DW
D000818:Animals; D001921:Brain / Q000196:embryology*; D002762:Cholecalciferol / Q000502:physiology*; D051381:Rats; D012559:Schizophrenia / Q000453:epidemiology
D002762:Cholecalciferol